A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children

Clinical trial NCT02092077 · TERMINATED

Trial details

NCT number: NCT02092077
Sponsor: Teva Pharmaceutical Industries, Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Growth Hormone-Deficiency

Start date: 2014-04-30
Primary completion: 2016-04-30
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.